Medical device and Drugs trial converge, so does Pharma and Medtech CROs
The statement above is on grounds of recent uptick that clinical research industry is witnessing on supply front. Couple of days back we had published CSSI Lifescience’s launch of fully integrated medical device CRO, and now CiToxLAB acquiring AccelLAB.
The trend of acquisitions is justifiable, as Healthcare industry embraces convergence of medical devices and drugs. Combination products are buzz words of healthcare industry and no CRO; big or small are leaving any stone un-turned to address booming client need.